These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39432642)

  • 1. Exploring the role of aggrephagy-related signatures in immune microenvironment, prognosis, and therapeutic strategies of breast cancer.
    Ye C
    Medicine (Baltimore); 2024 Oct; 103(42):e39999. PubMed ID: 39432642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.
    Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H
    BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Apoptosis-Related Specific Risk Model for Breast Cancer: From Genomic Analysis to Precision Medicine.
    Li Z; Liu H; Zhang M; Wang J; Peng Q; Jiang N; Wei Y
    Front Biosci (Landmark Ed); 2024 Jun; 29(7):239. PubMed ID: 39082332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.
    Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D
    Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.
    Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P
    J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANoptosis-related molecular clustering and prognostic signature associated with the immune landscape and therapy response in breast cancer.
    Cao Y; Guan L; Yang L; Wei C
    Medicine (Baltimore); 2024 Sep; 103(37):e39511. PubMed ID: 39287311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer.
    Ouyang W; Liu Y; Huang H; Tan Y; Huang Z; Jia X; Yu Y; Yao H
    Aging (Albany NY); 2024 May; 16(9):7818-7844. PubMed ID: 38700505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H
    Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer.
    Wang L; Li J; Mei N; Chen H; Niu L; He J; Wang R
    Sci Rep; 2024 Jul; 14(1):16586. PubMed ID: 39020010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment.
    Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F
    Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
    Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
    Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
    Li J; Qi C; Li Q; Liu F
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Glycolytic Activity Signature Reveals CCNB2 as a Key Therapeutic Target in Triple-Negative Breast Cancer.
    Liang J; Ma H; Zhang S; Dong Y; Zheng J; Zeng L; Xiong X; Huang W; Yin Q; Zheng X
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):308. PubMed ID: 39206892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.